StreetInsider.com News Articles

Form DEFA14A 20/20 Biolabs, Inc.

Wed, 21 Oct 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20261021/27216555.html

Form DEF 14A 20/20 Biolabs, Inc. For: Dec 09

Wed, 21 Oct 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20261021/27216514.html

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

Thu, 15 Oct 2026 08:45:00 -0400

AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034

NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Artificial intelligence is starting to change the way healthcare works, and the opportunity is getting harder to ignore. From spotting diseases earlier to helping doctors make better decisions, AI is finding its way into more areas of medicine. Hospitals are looking for ways to improve patient care, reduce costs and handle growing workloads, while pharmaceutical companies are turning to AI to speed up drug discovery and

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

Thu, 15 Oct 2026 08:45:00 -0400

AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

Thu, 15 Oct 2026 08:45:00 -0400

AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

Thu, 15 Oct 2026 08:45:00 -0400

AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

Thu, 15 Oct 2026 08:45:00 -0400

AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

Thu, 15 Oct 2026 08:45:00 -0400

AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

Thu, 15 Oct 2026 08:45:00 -0400

AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

Thu, 15 Oct 2026 08:45:00 -0400

AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

Thu, 15 Oct 2026 08:45:00 -0400

AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

Thu, 15 Oct 2026 08:45:00 -0400

AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034

HEALWELL AI Named to TIME's World's Top HealthTech Companies of 2026 and Announces 12 Real-World Evidence and Clinical AI Presentations at International Conferences This Fall.

Thu, 15 Oct 2026 06:00:00 -0400

HEALWELL has been named to TIME's World's Top HealthTech Companies of 2026, a ranking of 500 companies.
HEALWELL and its collaborators are presenting 12 scientific abstracts and presentations at 8 international conferences this fall including 8 ethics-approved real-world evidence ("RWE") studies with 7 life sciences partners and 4 HEALWELL-led presentations.

Toronto, Ontario--(Newsfile Corp. - October 15, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, today announced that it has been named to TIME's list of the World's Top HealthTech Companies of 2026, and that, together with its life

HEALWELL AI Named to TIME's World's Top HealthTech Companies of 2026 and Announces 12 Real-World Evidence and Clinical AI Presentations at International Conferences This Fall.

Thu, 15 Oct 2026 06:00:00 -0400

HEALWELL has been named to TIME's World's Top HealthTech Companies of 2026, a ranking of 500 companies.
HEALWELL and its collaborators are presenting 12 scientific abstracts and presentations at 8 international conferences this fall including 8 ethics-approved real-world evidence ("RWE") studies with 7 life sciences partners and 4 HEALWELL-led presentations.

Form PRE 14A 20/20 Biolabs, Inc. For: Oct 06

Tue, 06 Oct 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20261006/27155974.html

HEALWELL AI Provides Research Update on Peer-Reviewed MyHealthNB Study and Global Recognition of DARWEN(TM)

Tue, 06 Oct 2026 06:00:00 -0400

Peer-reviewed research published in the Journal of Medical Internet Research (JMIR) reports that VeroSource's MyHealth patient app was associated with statistically significant, self-reported improvements in patient empowerment and healthcare engagement.
HEALWELL's DARWEN™ AI abstract was selected as one of just 10 additional submissions to be featured in the HealthAI Global Governance Forum 2026's "Beyond the Room" digital programme.

Toronto, Ontario--(Newsfile Corp. - October 6, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, today provided a research update highlighting peer-reviewed research involving its VeroSource business and international recognition of its DARWEN™

HEALWELL AI Provides Research Update on Peer-Reviewed MyHealthNB Study and Global Recognition of DARWEN(TM)

Tue, 06 Oct 2026 06:00:00 -0400

Peer-reviewed research published in the Journal of Medical Internet Research (JMIR) reports that VeroSource's MyHealth patient app was associated with statistically significant, self-reported improvements in patient empowerment and healthcare engagement.
HEALWELL's DARWEN™ AI abstract was selected as one of just 10 additional submissions to be featured in the HealthAI Global Governance Forum 2026's "Beyond the Room" digital programme.

20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026

Fri, 02 Oct 2026 08:31:00 -0400

Management to Hold One-on-One Meetings with Institutional Investors at the Hard Rock Hotel New York

GAITHERSBURG, Md., Oct. 02, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX) (the “Company”), an early market entrant in AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today announced that President and Chief Executive Officer Jonathan Cohen and Chief Financial Officer Alan Bergman will participate in the Maxim Growth Summit 2026, being held October 13 and 14, 2026 at the Hard Rock Hotel New York. The Summit’s healthcare program

20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026

Fri, 02 Oct 2026 08:31:00 -0400

Management to Hold One-on-One Meetings with Institutional Investors at the Hard Rock Hotel New York

WELLSTAR Commences Trading on TSX Venture Exchange and Announces Its Board of Directors

Thu, 01 Oct 2026 06:00:00 -0400

WELLSTAR commences trading on the TSX Venture Exchange at the market open on October 1, 2026, under the ticker symbol "WSTR".
The Company also announces the five-member Board of Directors will be led by Hamed Shahbazi (Chairman), Amir Javidan, Evelyn Sutherland, Matt Mattox and Sue Paish. WELLSTAR's Board of Directors combines healthcare, technology, capital markets and governance experience to support WELLSTAR's next phase of growth.

Vancouver, British Columbia--(Newsfile Corp. - October 1, 2026) - WELLSTAR Technologies Corp. (TSXV: WSTR) (the "Company" or "WELLSTAR"), a leading provider of digital health solutions for Canadian healthcare providers, is pleased to announce that the Company's

WELLSTAR Commences Trading on TSX Venture Exchange and Announces Its Board of Directors

Thu, 01 Oct 2026 06:00:00 -0400

WELLSTAR commences trading on the TSX Venture Exchange at the market open on October 1, 2026, under the ticker symbol "WSTR".
The Company also announces the five-member Board of Directors will be led by Hamed Shahbazi (Chairman), Amir Javidan, Evelyn Sutherland, Matt Mattox and Sue Paish. WELLSTAR's Board of Directors combines healthcare, technology, capital markets and governance experience to support WELLSTAR's next phase of growth.

WELLSTAR Commences Trading on TSX Venture Exchange and Announces Its Board of Directors

Thu, 01 Oct 2026 06:00:00 -0400

WELLSTAR commences trading on the TSX Venture Exchange at the market open on October 1, 2026, under the ticker symbol "WSTR".
The Company also announces the five-member Board of Directors will be led by Hamed Shahbazi (Chairman), Amir Javidan, Evelyn Sutherland, Matt Mattox and Sue Paish. WELLSTAR's Board of Directors combines healthcare, technology, capital markets and governance experience to support WELLSTAR's next phase of growth.

WELLSTAR Commences Trading on TSX Venture Exchange and Announces Its Board of Directors

Thu, 01 Oct 2026 06:00:00 -0400

WELLSTAR commences trading on the TSX Venture Exchange at the market open on October 1, 2026, under the ticker symbol "WSTR".
The Company also announces the five-member Board of Directors will be led by Hamed Shahbazi (Chairman), Amir Javidan, Evelyn Sutherland, Matt Mattox and Sue Paish. WELLSTAR's Board of Directors combines healthcare, technology, capital markets and governance experience to support WELLSTAR's next phase of growth.

WELLSTAR Commences Trading on TSX Venture Exchange and Announces Its Board of Directors

Thu, 01 Oct 2026 06:00:00 -0400

WELLSTAR commences trading on the TSX Venture Exchange at the market open on October 1, 2026, under the ticker symbol "WSTR".
The Company also announces the five-member Board of Directors will be led by Hamed Shahbazi (Chairman), Amir Javidan, Evelyn Sutherland, Matt Mattox and Sue Paish. WELLSTAR's Board of Directors combines healthcare, technology, capital markets and governance experience to support WELLSTAR's next phase of growth.

WELLSTAR Commences Trading on TSX Venture Exchange and Announces Its Board of Directors

Thu, 01 Oct 2026 06:00:00 -0400

WELLSTAR commences trading on the TSX Venture Exchange at the market open on October 1, 2026, under the ticker symbol "WSTR".
The Company also announces the five-member Board of Directors will be led by Hamed Shahbazi (Chairman), Amir Javidan, Evelyn Sutherland, Matt Mattox and Sue Paish. WELLSTAR's Board of Directors combines healthcare, technology, capital markets and governance experience to support WELLSTAR's next phase of growth.